home All News open_in_new Full Article
Bitter Pill For Sun Pharma? Goldman Sachs Explains Why The Drugmaker May Face Pressure
today 3 w. ago attach_file Events
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Events
attach_file
Events
3 w. ago
US Tariffs: Only Sun Pharma Exposed To Some Headline Risk, But With Limited Earnings Impact
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Economics
attach_file
Politics
attach_file
Politics
attach_file
Politics
ID: 764178714